Suppression of SV40 tumors after immunization with group A Streptococcus pyogenes and Bordetella pertussis.
D000818:Animals; D000907:Antibodies, Bacterial / Q000032:analysis; D000912:Antibodies, Neoplasm; D000937:Antigen-Antibody Reactions; D000951:Antigens, Neoplasm / Q000032:analysis; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D001886:Bordetella pertussis / Q000276:immunology*; D006224:Cricetinae; D003429:Cross Reactions; D005354:Fibrosarcoma / Q000097:blood / Q000276:immunology / Q000517:prevention & control*; D005944:Glucosamine; D008024:Ligands; D008297:Male; D009374:Neoplasms, Experimental / Q000097:blood / Q000276:immunology; D009438:Neuraminic Acids / Q000097:blood; D010567:Pertussis Vaccine / Q000627:therapeutic use*; D011135:Polysaccharides, Bacterial / Q000032:analysis; D012210:Rhamnose; D012513:Sarcoma, Experimental / Q000517:prevention & control; D013539:Simian virus 40; D013297:Streptococcus pyogenes / Q000276:immunology*
D000907:Antibodies, Bacterial; D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D001428:Bacterial Vaccines; D008024:Ligands; D009438:Neuraminic Acids; D010567:Pertussis Vaccine; D011135:Polysaccharides, Bacterial; D005944:Glucosamine; D012210:Rhamnose